Mechanisms of Acquired BRAF Inhibitor Resistance in Melanoma: A Systematic Review.
BRAF inhibitors
melanoma
metastasis
microenvironment
resistance
therapy
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
29 Sep 2020
29 Sep 2020
Historique:
received:
27
08
2020
revised:
21
09
2020
accepted:
25
09
2020
entrez:
2
10
2020
pubmed:
3
10
2020
medline:
3
10
2020
Statut:
epublish
Résumé
This systematic review investigated the literature on acquired v-raf murine sarcoma viral oncogene homolog B1 (BRAF) inhibitor resistance in patients with melanoma. We searched MEDLINE for articles on BRAF inhibitor resistance in patients with melanoma published since January 2010 in the following areas: (1) genetic basis of resistance; (2) epigenetic and transcriptomic mechanisms; (3) influence of the immune system on resistance development; and (4) combination therapy to overcome resistance. Common resistance mutations in melanoma are BRAF splice variants,
Identifiants
pubmed: 33003483
pii: cancers12102801
doi: 10.3390/cancers12102801
pmc: PMC7600801
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Nat Med. 2019 Jun;25(6):941-946
pubmed: 31171878
Cell Death Dis. 2013 Nov 07;4:e914
pubmed: 24201813
Cells. 2020 Jan 07;9(1):
pubmed: 31936151
Mol Cancer Ther. 2014 Feb;13(2):353-63
pubmed: 24398428
Oncotarget. 2016 May 17;7(20):29689-707
pubmed: 27102439
J Invest Dermatol. 2015 Feb;135(2):532-541
pubmed: 25243790
Nat Commun. 2018 Jun 27;9(1):2500
pubmed: 29950559
Cancer Lett. 2017 Nov 1;408:43-54
pubmed: 28826720
Cell Rep. 2013 Sep 26;4(6):1090-9
pubmed: 24055054
Cancers (Basel). 2020 Feb 22;12(2):
pubmed: 32098410
Oncol Rep. 2017 Nov;38(5):2741-2751
pubmed: 29048639
Oncotarget. 2015 Jul 10;6(19):17753-63
pubmed: 25980496
J Biol Chem. 2012 Aug 10;287(33):28087-98
pubmed: 22730329
J Exp Clin Cancer Res. 2019 Jun 21;38(1):272
pubmed: 31227006
Oncotarget. 2017 May 25;8(41):69204-69218
pubmed: 29050198
Mol Cancer Ther. 2014 Dec;13(12):2793-2804
pubmed: 25349308
Oncotarget. 2016 May 24;7(21):30453-60
pubmed: 27028853
Cancer Res Treat. 2017 Oct;49(4):947-959
pubmed: 28052651
Nature. 2014 Sep 4;513(7516):105-9
pubmed: 25079330
Front Mol Biosci. 2020 Jul 14;7:154
pubmed: 32760738
Cancer Res. 2019 Jun 1;79(11):2947-2961
pubmed: 30987999
Cancer Discov. 2018 May;8(5):568-581
pubmed: 29496664
Eur J Cancer. 2016 Mar;55:98-110
pubmed: 26790143
Int J Oncol. 2016 Sep;49(3):953-60
pubmed: 27572939
N Engl J Med. 2019 Aug 15;381(7):626-636
pubmed: 31166680
Cell Death Dis. 2018 Jun 7;9(6):679
pubmed: 29880840
Cancer Cell. 2019 Jul 8;36(1):68-83.e9
pubmed: 31257073
Cancer Cell Int. 2020 Jan 30;20:36
pubmed: 32021565
Oncogene. 2015 Jan 22;34(4):531-6
pubmed: 24469059
Nature. 2012 Jul 26;487(7408):500-4
pubmed: 22763439
Mol Cancer. 2014 Apr 16;13:83
pubmed: 24735930
Nature. 2015 Jan 29;517(7536):583-8
pubmed: 25494202
Oncogene. 2014 Feb 27;33(9):1158-66
pubmed: 23455323
Cancer Res. 2014 Sep 1;74(17):4845-4852
pubmed: 25056119
Immunol Res. 2011 Aug;50(2-3):294-302
pubmed: 21717063
J Invest Dermatol. 2015 May;135(5):1368-1376
pubmed: 25615552
Dis Markers. 2016;2016:9406319
pubmed: 27642217
Melanoma Res. 2019 Aug;29(4):390-400
pubmed: 30741840
Mol Cancer Ther. 2011 Dec;10(12):2426-36
pubmed: 21998291
J Invest Dermatol. 2012 Jul;132(7):1850-9
pubmed: 22437314
Pigment Cell Melanoma Res. 2019 Mar;32(2):292-302
pubmed: 30281931
Nature. 2018 Jun;558(7711):605-609
pubmed: 29925953
Mol Cancer Ther. 2014 Jan;13(1):16-26
pubmed: 24249714
Mol Cancer Ther. 2019 Mar;18(3):706-717
pubmed: 30523048
Cell Death Dis. 2018 Jan 18;9(2):29
pubmed: 29348439
EMBO J. 2016 Mar 1;35(5):462-78
pubmed: 26668268
Cancer Res. 2019 May 1;79(9):2244-2256
pubmed: 30833419
J Transl Med. 2016 Apr 14;14:88
pubmed: 27075584
Target Oncol. 2020 Feb;15(1):101-113
pubmed: 31980996
PLoS One. 2015 Apr 06;10(4):e0123410
pubmed: 25844720
Cell Rep. 2017 Dec 5;21(10):2796-2812
pubmed: 29212027
Oncotarget. 2015 Mar 10;6(7):5118-33
pubmed: 25742786
Cell Death Dis. 2016 Mar 10;7:e2135
pubmed: 26962685
ACS Chem Biol. 2014 Apr 18;9(4):1003-14
pubmed: 24506253
Mol Oncol. 2020 Aug;14(8):1817-1832
pubmed: 32330348
Cancer Med. 2017 Jul;6(7):1652-1664
pubmed: 28573821
Nat Med. 2019 Jun;25(6):936-940
pubmed: 31171879
Int J Oncol. 2020 Jun;56(6):1429-1441
pubmed: 32236593
Front Biosci (Schol Ed). 2019 Mar 1;11:193-202
pubmed: 30844744
Oncotarget. 2015 Dec 1;6(38):40535-56
pubmed: 26497853
Cancer Res. 2019 Oct 1;79(19):5074-5087
pubmed: 31416844
PLoS One. 2019 Apr 2;14(4):e0214884
pubmed: 30939167
Mol Cell Proteomics. 2014 Jul;13(7):1844-54
pubmed: 24760959
Mol Oncol. 2016 Jan;10(1):73-84
pubmed: 26365896
Apoptosis. 2019 Aug;24(7-8):596-611
pubmed: 30989459
Mol Cancer Ther. 2019 Sep;18(9):1637-1648
pubmed: 31270153
Clin Cancer Res. 2013 Feb 1;19(3):598-609
pubmed: 23095323
Nature. 2010 Dec 16;468(7326):973-7
pubmed: 21107323
J Invest Dermatol. 2020 Jun;140(6):1295-1299.e1
pubmed: 31705876
Nat Commun. 2014 Dec 02;5:5694
pubmed: 25452114
Cancer Metastasis Rev. 2013 Dec;32(3-4):643-71
pubmed: 23903773
Oncotarget. 2017 Dec 15;9(5):6174-6187
pubmed: 29464063
Lancet. 2015 Aug 1;386(9992):444-51
pubmed: 26037941
Cell Commun Signal. 2010 Sep 07;8:23
pubmed: 20822528
Oncotarget. 2016 Jan 19;7(3):2734-53
pubmed: 26673621
Clin Cancer Res. 2017 Sep 1;23(17):5238-5245
pubmed: 28536307
Clin Cancer Res. 2014 Apr 1;20(7):1965-77
pubmed: 24463458
Int J Mol Sci. 2019 Aug 27;20(17):
pubmed: 31461993
Nat Cell Biol. 2019 Jun;21(6):778-790
pubmed: 31160710
Oncol Rep. 2017 Feb;37(2):1270-1276
pubmed: 28035401
Cancer Discov. 2014 Jan;4(1):69-79
pubmed: 24265152
Mol Cell Proteomics. 2019 Jun;18(6):1096-1109
pubmed: 30890564
Proc Natl Acad Sci U S A. 2016 Aug 23;113(34):E5005-13
pubmed: 27503895
J Cancer. 2018 Nov 24;9(24):4665-4676
pubmed: 30588251
Nature. 2011 Nov 23;480(7377):387-90
pubmed: 22113612
Oncotarget. 2013 Nov;4(11):1986-98
pubmed: 24161908
Eur J Immunol. 2016 Feb;46(2):409-19
pubmed: 26564811
Oncogene. 2020 Feb;39(7):1466-1483
pubmed: 31659259
Lancet Oncol. 2018 Oct;19(10):1315-1327
pubmed: 30219628
Mol Carcinog. 2017 May;56(5):1515-1525
pubmed: 28052407
Pigment Cell Melanoma Res. 2015 May;28(3):318-23
pubmed: 25515853
Nat Cell Biol. 2016 Oct;18(10):1090-101
pubmed: 27617932
PLoS Comput Biol. 2019 Jun 5;15(6):e1007034
pubmed: 31166947
Am Soc Clin Oncol Educ Book. 2012;:680-4
pubmed: 24451818
Cancer Lett. 2017 Oct 10;406:1-11
pubmed: 28774796
Mol Cancer Ther. 2014 Oct;13(10):2253-63
pubmed: 25122067
Nat Commun. 2018 Nov 14;9(1):4775
pubmed: 30429474
Cancer Res. 2017 Apr 1;77(7):1599-1610
pubmed: 28202513
Biomed Pharmacother. 2019 Jan;109:2548-2560
pubmed: 30551515
Nat Commun. 2019 Nov 14;10(1):5167
pubmed: 31727888
Cancer Discov. 2017 Nov;7(11):1248-1265
pubmed: 28864476
Front Oncol. 2020 Apr 03;10:442
pubmed: 32346533
Oncogene. 2017 Aug 10;36(32):4585-4596
pubmed: 28368422
Cell. 2018 May 31;173(6):1413-1425.e14
pubmed: 29754815
J Exp Clin Cancer Res. 2020 Feb 21;39(1):38
pubmed: 32085796
Lancet Oncol. 2016 Sep;17(9):1248-60
pubmed: 27480103
Ann Oncol. 2019 Dec 1;30(12):1884-1901
pubmed: 31566661
Cancer Lett. 2019 Feb 1;442:453-463
pubmed: 30481565
Autophagy. 2017 Sep 2;13(9):1512-1527
pubmed: 28722539
Oncotarget. 2017 Nov 22;8(66):110257-110272
pubmed: 29299145
Org Biomol Chem. 2017 Apr 18;15(16):3455-3465
pubmed: 28368067
Mol Oncol. 2019 Feb;13(2):480-494
pubmed: 30582770
J Invest Dermatol. 2017 Oct;137(10):2187-2196
pubmed: 28599981
Cancers (Basel). 2019 Sep 25;11(10):
pubmed: 31557826
J Invest Dermatol. 2020 Jun;140(6):1253-1265
pubmed: 31877318
Proc Natl Acad Sci U S A. 2013 Mar 12;110(11):4321-6
pubmed: 23447565
N Engl J Med. 2017 Nov 9;377(19):1813-1823
pubmed: 28891408
Clin Transl Oncol. 2016 Aug;18(8):848-58
pubmed: 26519363
N Engl J Med. 2015 Jan 1;372(1):30-9
pubmed: 25399551
Cancer Res. 2017 Nov 15;77(22):6240-6252
pubmed: 28986383
Cancer Res. 2014 Aug 1;74(15):4122-32
pubmed: 25035390
Biomol Ther (Seoul). 2013 Mar;21(2):114-20
pubmed: 24009868
Front Oncol. 2015 Jun 16;5:135
pubmed: 26137449
Cancers (Basel). 2020 Jul 07;12(7):
pubmed: 32645969
Oncogene. 2019 May;38(22):4384-4396
pubmed: 30710146
iScience. 2019 Jun 28;16:453-467
pubmed: 31229894
Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4583-4591
pubmed: 30782837
Oncotarget. 2017 May 30;8(22):35761-35775
pubmed: 28415756
Am J Clin Exp Immunol. 2014 Feb 27;3(1):43-56
pubmed: 24660121
Cancer Res. 2013 Dec 1;73(23):7043-55
pubmed: 24121489
PLoS One. 2012;7(8):e43369
pubmed: 22912864
Clin Cancer Res. 2014 May 15;20(10):2516-22
pubmed: 24664307
Nat Med. 2016 Sep;22(9):1056-61
pubmed: 27500726
Cancer Res. 2013 Aug 1;73(15):4840-51
pubmed: 23737487
Cancer Biol Ther. 2017 Feb;18(2):106-114
pubmed: 27786591
Clin Cancer Res. 2016 Apr 1;22(7):1592-602
pubmed: 26673799
Am J Med Sci. 2013 Dec;346(6):494-8
pubmed: 24051957
Am J Cancer Res. 2015 Mar 15;5(4):1507-18
pubmed: 26101714
Nat Med. 2013 May;19(5):626-630
pubmed: 23603816
Nat Commun. 2014 Dec 15;5:5712
pubmed: 25502142
Cell Discov. 2015 Oct 27;1:15030
pubmed: 27462428
Mol Cell Oncol. 2015 Apr 27;3(1):e1021441
pubmed: 27308535
Proc Natl Acad Sci U S A. 2015 Feb 10;112(6):E536-45
pubmed: 25624498
Mol Cancer Ther. 2019 Feb;18(2):289-300
pubmed: 30482853
Eur J Med Chem. 2020 Jan 15;186:111885
pubmed: 31784187
Int J Nanomedicine. 2019 May 02;14:3111-3128
pubmed: 31118626
Cancers (Basel). 2018 Feb 16;10(2):
pubmed: 29462906
Cancer Discov. 2014 Jan;4(1):94-109
pubmed: 24265153
Pigment Cell Melanoma Res. 2015 Jul;28(4):431-41
pubmed: 25903073
JCI Insight. 2018 Jul 26;3(14):
pubmed: 30046005
Cancers (Basel). 2019 Oct 24;11(11):
pubmed: 31653096
Clin Cancer Res. 2016 Dec 15;22(24):5966-5970
pubmed: 27797970
Biomark Res. 2017 May 11;5:17
pubmed: 28503307
Mol Cancer Ther. 2015 Jun;14(6):1354-64
pubmed: 25873592
Science. 2016 Sep 30;353(6307):1545-1549
pubmed: 27708104
PLoS One. 2015 May 27;10(5):e0125021
pubmed: 26018524
Mol Syst Biol. 2014 Dec 23;10:772
pubmed: 25538140
Genes Genomics. 2019 Nov;41(11):1273-1280
pubmed: 31388978
Nature. 2017 Aug 17;548(7667):343-346
pubmed: 28792927
J Am Med Inform Assoc. 2016 Jul;23(4):721-30
pubmed: 27026619
Clin Cancer Res. 2019 May 1;25(9):2783-2794
pubmed: 30765391
Oncotarget. 2018 Dec 11;9(97):36945-36965
pubmed: 30651927
Mol Cell Biochem. 2014 Jul;392(1-2):239-47
pubmed: 24671490
Nature. 2010 Dec 16;468(7326):968-72
pubmed: 21107320
Mol Cancer Ther. 2015 Dec;14(12):2700-11
pubmed: 26351322
PLoS One. 2018 Jan 9;13(1):e0190834
pubmed: 29315345
J Dermatol. 2018 Dec;45(12):1434-1439
pubmed: 30222203
Cell. 2014 Feb 27;156(5):986-1001
pubmed: 24581497
Biochim Biophys Acta Gen Subj. 2017 Nov;1861(11 Pt B):2980-2992
pubmed: 28408301
J Invest Dermatol. 2016 Dec;136(12):2475-2484
pubmed: 27498344
Cancer Res. 2011 Apr 1;71(7):2750-60
pubmed: 21317224
Mol Cancer Ther. 2014 Jun;13(6):1599-610
pubmed: 24651527
Lancet Oncol. 2016 Dec;17(12):1743-1754
pubmed: 27864013
Nat Commun. 2018 Aug 24;9(1):3440
pubmed: 30143629
Clin Cancer Res. 2015 Jan 1;21(1):98-105
pubmed: 25370473
Nat Commun. 2015 May 14;6:7103
pubmed: 25971842
Int J Mol Sci. 2018 Jan 18;19(1):
pubmed: 29346301
Oncoimmunology. 2018 Apr 18;7(8):e1450127
pubmed: 30221038
Oncotarget. 2017 Mar 14;8(11):17795-17809
pubmed: 28147313
PLoS One. 2014 Apr 14;9(4):e94748
pubmed: 24733413
Sci Signal. 2015 Aug 18;8(390):ra82
pubmed: 26286024
Mol Cancer Ther. 2012 Apr;11(4):909-20
pubmed: 22389471
PLoS One. 2014 Jul 01;9(7):e101286
pubmed: 24983357
Cancer Res. 2016 May 1;76(9):2720-30
pubmed: 26984758
J Immunother. 2015 Jan;38(1):12-23
pubmed: 25415284
J Am Coll Surg. 2018 Apr;226(4):526-537
pubmed: 29369798
Med Sci Monit. 2020 Apr 10;26:e920957
pubmed: 32273491
Lancet Oncol. 2018 May;19(5):603-615
pubmed: 29573941
Mol Cancer Ther. 2014 Apr;13(4):823-32
pubmed: 24448821
ACS Nano. 2018 Dec 26;12(12):11936-11948
pubmed: 30444343
EBioMedicine. 2016 Jun;8:132-149
pubmed: 27428425
Br J Cancer. 2010 Jun 8;102(12):1724-30
pubmed: 20531415
J Med Chem. 2014 Mar 27;57(6):2692-703
pubmed: 24588073
Cancer Cell. 2012 Jan 17;21(1):7-9
pubmed: 22264784
Nat Commun. 2019 Apr 12;10(1):1693
pubmed: 30979895
Oncotarget. 2016 Aug 16;7(33):53558-53570
pubmed: 27448964
Cancer Discov. 2016 Apr;6(4):382-99
pubmed: 26984351
Int J Cancer. 2018 Dec 15;143(12):3131-3142
pubmed: 29905375
EMBO Mol Med. 2016 Oct 4;8(10):1143-1161
pubmed: 27596438
Int J Cancer. 2018 May 1;142(9):1926-1937
pubmed: 29210065
Future Oncol. 2020 Apr;16(11):619-629
pubmed: 32125175
Oncotarget. 2019 Mar 1;10(18):1669-1687
pubmed: 30899440
J Cell Mol Med. 2020 Jan;24(1):465-475
pubmed: 31758648
Cancer Chemother Pharmacol. 2018 Feb;81(2):325-332
pubmed: 29222604
Clin Cancer Res. 2018 Nov 15;24(22):5516-5524
pubmed: 29674508
JAMA Oncol. 2018 Oct 1;4(10):1382-1388
pubmed: 30073321
Oncotarget. 2014 Apr 15;5(7):1926-41
pubmed: 24732172
Oncogenesis. 2020 May 5;9(5):44
pubmed: 32371878
Cancer Res. 2018 Feb 15;78(4):1017-1030
pubmed: 29229605
Oncotarget. 2016 Apr 12;7(15):19997-20015
pubmed: 26918352
Oncotarget. 2015 Jun 20;6(17):15250-64
pubmed: 26098773
Int J Mol Sci. 2019 Sep 11;20(18):
pubmed: 31514305
Oncotarget. 2015 Sep 22;6(28):24823-41
pubmed: 26208478
Lancet Oncol. 2017 Apr;18(4):464-472
pubmed: 28268064
Cancer Lett. 2017 Sep 28;404:70-78
pubmed: 28720543
Oncotarget. 2016 Jun 28;7(26):39473-39485
pubmed: 27250023
Nature. 2012 Jul 26;487(7408):505-9
pubmed: 22763448
Neoplasia. 2018 Apr;20(4):401-409
pubmed: 29558679
Mol Cancer Ther. 2016 Aug;15(8):1859-69
pubmed: 27297867
Eur J Cancer. 2018 Sep;101:229-235
pubmed: 30096703
J Mol Diagn. 2013 Mar;15(2):220-6
pubmed: 23273605
PLoS One. 2013;8(2):e56134
pubmed: 23418523
J Clin Oncol. 2018 Mar 1;36(7):667-673
pubmed: 28991513
Oncogene. 2017 Jan 19;36(3):423-428
pubmed: 27321184
J Transl Med. 2010 Jul 14;8:67
pubmed: 20630094
Mol Carcinog. 2020 Jan;59(1):5-14
pubmed: 31571292
Pigment Cell Melanoma Res. 2015 Sep;28(5):572-89
pubmed: 26112748
NPJ Precis Oncol. 2018 Mar 7;2(1):7
pubmed: 29872725
Nature. 2014 Apr 3;508(7494):118-22
pubmed: 24670642
Acta Pharmacol Sin. 2019 Feb;40(2):268-278
pubmed: 29777202
Biochem Pharmacol. 2015 May 1;95(1):16-27
pubmed: 25795251
Cancer Discov. 2015 Feb;5(2):143-53
pubmed: 25472943
Cell Rep. 2015 Jun 9;11(9):1458-73
pubmed: 26027934
Nat Commun. 2012 Mar 06;3:724
pubmed: 22395615
Pharmaceutics. 2019 Oct 01;11(10):
pubmed: 31581483
Cell Death Dis. 2018 May 29;9(6):640
pubmed: 29844307
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Mol Cancer. 2012 Oct 05;11:75
pubmed: 23039341
Biomol Ther (Seoul). 2019 May 1;27(3):302-310
pubmed: 30293252
Int J Cancer. 2018 May 15;142(10):2139-2152
pubmed: 29243224
Cancer Discov. 2013 Jul;3(7):742-50
pubmed: 23614898
Cancer Immunol Res. 2019 Jan;7(1):86-99
pubmed: 30413431
Mol Cancer Ther. 2013 Jun;12(6):901-12
pubmed: 23538902
Cancer Discov. 2013 Feb;3(2):158-67
pubmed: 23242808
Oncotarget. 2017 May 9;8(41):69477-69492
pubmed: 29050218
Pigment Cell Melanoma Res. 2014 Jan;27(1):124-33
pubmed: 24112705
Cell Discov. 2016 Sep 06;2:16028
pubmed: 27648299
J Proteome Res. 2016 Dec 2;15(12):4476-4489
pubmed: 27934295
J Natl Cancer Inst. 2018 Mar 1;110(3):
pubmed: 29309612
PLoS One. 2015 Apr 27;10(4):e0125028
pubmed: 25915038
Cell Death Dis. 2017 Aug 31;8(8):e3029
pubmed: 29048432
J Biol Chem. 2014 Oct 3;289(40):27714-26
pubmed: 25063807
J Clin Invest. 2014 Jul;124(7):2877-90
pubmed: 24865425
Handb Exp Pharmacol. 2018;249:129-143
pubmed: 28238077
Pigment Cell Melanoma Res. 2015 Jul;28(4):417-30
pubmed: 25854919
Oncotarget. 2017 Mar 7;8(10):16367-16386
pubmed: 28146421
Nat Med. 2019 Jun;25(6):929-935
pubmed: 31171876
J Clin Invest. 2014 Mar;124(3):1406-17
pubmed: 24569374
Am J Cancer Res. 2019 Dec 01;9(12):2580-2598
pubmed: 31911848
Mol Cancer Ther. 2016 Jul;15(7):1460-71
pubmed: 27196754
Cell Death Differ. 2019 Jul;26(7):1267-1282
pubmed: 30254376
J Biol Chem. 2014 Nov 21;289(47):32671-81
pubmed: 25294877
J Oncol. 2019 Jul 3;2019:1697913
pubmed: 31354817
Cancer Discov. 2013 Mar;3(3):260-3
pubmed: 23475878
Clin Cancer Res. 2019 Nov 15;25(22):6852-6867
pubmed: 31375515
Cancer Discov. 2013 Mar;3(3):350-62
pubmed: 23288408
Clin Cancer Res. 2015 Apr 1;21(7):1652-64
pubmed: 25617424
Mol Cell Proteomics. 2018 Apr;17(4):550-564
pubmed: 29255136
PLoS One. 2011;6(12):e28973
pubmed: 22194965
N Engl J Med. 2014 Nov 13;371(20):1877-88
pubmed: 25265492
Eur J Cancer. 2015 Dec;51(18):2792-9
pubmed: 26608120
Nat Rev Cancer. 2014 Jul;14(7):455-67
pubmed: 24957944
Int J Cancer. 2020 Mar 1;146(5):1409-1420
pubmed: 31702822
Lab Invest. 2017 Feb;97(2):176-186
pubmed: 27775691
Front Oncol. 2015 May 15;5:95
pubmed: 26029660
BMC Syst Biol. 2018 Apr 4;12(1):33
pubmed: 29615030
Target Oncol. 2015 Mar;10(1):77-84
pubmed: 24824730
Cancer Immunol Res. 2018 Mar;6(3):255-266
pubmed: 29382670
Mol Cancer Ther. 2017 Nov;16(11):2340-2350
pubmed: 28775144
Clin Cancer Res. 2014 Jul 1;20(13):3446-57
pubmed: 24812408
Pigment Cell Melanoma Res. 2019 Jul;32(4):576-583
pubmed: 30758912
J Invest Dermatol. 2015 Jul;135(7):1863-1872
pubmed: 25789707
Clin Cancer Res. 2013 Mar 1;19(5):1225-31
pubmed: 23307859